Cawthorn and coworkers found that high decorin expression was associated with lymph node metastasis and poor clinical outcome in breast cancer; thus, decorin was proposed as an adverse prognostic and predictive biomarker [45]. This evidence concerns the gene DCN and breast carcinoma.